Elisabeth H. Slager

Identification of phosphatidylinositol 4-kinase type II β as HLA class II-restricted target in graft versus leukemia reactivity

Marieke Griffioen, Edith D. van der Meijden, Elisabeth H. Slager et al. · Proceedings of the National Academy of Sciences · 2008 · 67 citations · Full text

Medicine, Hematology, Immunology +17

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer

Elisabeth H. Slager, M. Willy Honders, Edith D. van der Meijden et al. · Blood · 2006 · 65 citations

Medicine, Cancer Biology, Oncology +14

CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame

Elisabeth H. Slager, Martina Borghi, Carolien E. van der Minne et al. · The Journal of Immunology · 2003 · 52 citations · Full text

Life Sciences, Immunology, Oncology +17

Identification of Multiple HLA-DR-Restricted Epitopes of the Tumor-Associated Antigen CAMEL by CD4+ Th1/Th2 Lymphocytes

Elisabeth H. Slager, Caroline E. van der Minne, Margreet Krüse et al. · The Journal of Immunology · 2004 · 20 citations · Full text

Life Sciences, Immunology, Oncology +17

Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber

Elisabeth H. Slager, Caroline E. van der Minne, Jaap Goudsmit et al. · Cancer Gene Therapy · 2004 · 17 citations

Life Sciences, Immunology, Adaptive Immunity +8